INFLUENCE OF CpG ODN 2006 OLIGODEOXYNUCLEOTIDE ON CYTOKINE PRODUCTION BY BLOOD CELLS OF HUMANS VACCINATED AGAINST PLAGUE
This study presents data upon the effects of CpG oligonucleotide substance (CpG ODN 2006). The commercial preparation was applied in vitro as a single agent, or in combination with various cytokine production inducers. Spontaneous and induced cytokine levels were tested in cultures of human blood ce...
Enregistré dans:
Auteurs principaux: | S. N. Klyueva, T. P. Shmelkova, T. N. Schukovskaya |
---|---|
Format: | article |
Langue: | RU |
Publié: |
SPb RAACI
2015
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2f70e24f59f3496e92f5e4888e657b67 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies
par: Hanagata N
Publié: (2017) -
Effects of CpG oligodeoxynucleotide 1826 on acute radiation-induced lung injury in mice
par: Li,Xuan, et autres
Publié: (2016) -
CpG Oligodeoxynucleotides Attenuate OVA-Induced Allergic Airway Inflammation via Suppressing JNK-Mediated Endoplasmic Reticulum Stress
par: Zhang HY, et autres
Publié: (2021) -
Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice
par: Zhao Y, et autres
Publié: (2020) -
Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice [Corrigendum]
par: Zhao Y, et autres
Publié: (2021)